Skip to content
Stop using now Drug recall · FDA · Published December 17, 2019

Bull Platinum 30000 Capsule Recall: Unapproved Drug with Tadalafil

Motto International recalls Bull Platinum 30000 capsules because they contain undeclared tadalafil and lack FDA approval. Check your bottle if you bought them in Texas.

🇺🇸 FDA recall #D-0654-2020DrugBull Platinum ›
Take action

Contact the company

Recalling firmMotto International Corp1908 Royal Ln Ste 700 · Dallas, TX 75229-0269
✎ GovInfoNow plain-language explainer

Motto International Corp is recalling Bull Platinum 30000 Capsules (1000 mg) because the product was marketed without an approved New Drug Application or Abbreviated New Drug Application. Additionally, FDA analysis found that the capsules contain tadalafil, a prescription ingredient not listed on the label. Only 8 boxes were distributed in Texas. Read more at govinfonow.com/recall/37640-bull-platinum-30000-capsule-recall-unapproved-drug-with-tadalafil.

Source Summary by GovInfoNow · govinfonow.com/recall/37640-bull-platinum-30000-capsule-recall-unapproved-drug-with-tadalafil · Updated October 11, 2026 · FDA enforcement record: FDA #D-0654-2020

Cite this page

“Bull Platinum 30000 Capsule Recall: Unapproved Drug with Tadalafil.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/37640-bull-platinum-30000-capsule-recall-unapproved-drug-with-tadalafil. Based on FDA recall #D-0654-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0654-2020%22&limit=1).

The Food and Drug Administration announced on Dec. 17, 2019, that Motto International Corp voluntarily recalled Bull Platinum 30000 Capsules because they were marketed without an approved New Drug Application or Abbreviated New Drug Application. FDA analysis found the product contained tadalafil.

How to tell if you have it

  • Brand: Bull Platinum
  • Product: Bull Platinum 30000 Capsules, 1000 mg
  • Packaging: orange, white, yellow background with silver text in 2, 4 and 10 count blister cards
  • Manufacturer: Motto International Corp, Dallas, TX
  • Distribution: Texas
  • Quantity: 8 boxes

The hazard

The product was marketed without an approved New Drug Application or Abbreviated New Drug Application. FDA analysis found the product to contain tadalafil.

Context

GovInfoNow's records show other recent recalls of similar products include StuffbyNainax MR 7 SUPER 700000 Capsules (2025-12-15), Shoolin Pharma Chem Tadalafil Recall (2026-08-03) and Shoolin Pharma Chem Tadalafil 500g Recall (2026-08-03).

How to tell if you have this one

Look for orange, white, and yellow blister cards with silver text labeled "Bull Platinum 30000 Capsules, 1000 mg." The packaging comes in counts of 2, 4, or 10. The manufacturer is Motto International Corp of Dallas, TX. All lots remaining within expiry are included.

  • Brand
    Bull Platinum
  • Category
    Drug
FDA recall event · 4 products

All 4 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class I
  • Status
    Terminated
  • Distribution
    TX
Recall numberProduct, codes & lotsQuantity
D-0654-2020Bull Platinum 30000 Capsules, 1000 mg, in orange, white, yellow background with silver text, packaged in 2, 4 and 10 count blister cards, Motto International, Dallas, TX; All lots remaining within expiry.8 boxes
D-0655-2020Stallion Platinum 30000 Capsules in blue,orange,white background with red,white text in hologram paper packaging, packaged in 2, 4, 10 count blister cards, Motto International, Dallas, TX; All lots remaining within expiry.7 boxes
D-0656-2020Rhino 7 Platinum 30000 Capsules, in blue,orange,black background with red,white,blue,gray text in hologram paper packaging, packaged in 2, 4, and 10 count blister cards, Motto International, Dallas, TX; All lots remaining within expiry.5 boxes
D-0657-2020Panther Platinum 30000 Capsules, in green, black background with white, red text in hologram paper packaging, packaged in 2, 4, and 10 count blister cards, Motto International, Dallas, TX; All lots remaining within expiry.1 box
Based on the official FDA remedy

What to do — step by step

  1. Stop taking the capsules

    Do not consume any Bull Platinum 30000 Capsules found in your possession due to the presence of undeclared tadalafil.

  2. Discard or return the product

    The recall record does not specify a return address or disposal method, so you should dispose of the product safely where possible.

Where it went and when

Where it was distributed

Distributed in Texas.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: yesTXFlorida: not listedFL

FDA distribution: “TX” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Texas.

Recall timeline

FDA terminated this recall 22 months after the firm started it.

1. Firm started the recall: Dec 17, 201912. FDA classified it Class I: Jan 10, 202023. Published in FDA’s Enforcement Report: Jan 22, 202034. FDA terminated the recall: Oct 29, 2021420192021
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0654-2020 (December 17, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0654-2020 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA